NDC 68084-856-11 - Venlafaxine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-856
- Requested NDC
- 68084-856-11
- Package NDCs from labels
- 68084-856-11, 68084-856-01
- Manufacturer
- American Health Packaging
- Effective date
- 2024-08-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Venlafaxine - American Health Packaging | American Health Packaging | 2024-08-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68084-856-01 | Venlafaxine | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 9 | |
| 68084-856-11 | Venlafaxine | 1 in 1 BLISTER PACK | TABLET | 1 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-856-01 | EA - Each | 68084-856 | 028d920e-a47f-47d4-b6f4-602d38f642e8 | 1 | 2015-04-03 |
| 68084-856-11 | EA - Each | 68084-856 | 8739fd6f-1a93-4702-9c81-7eed0445a7a1 | 1 | 2015-04-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 7D7RX5A8MO | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| VENLAFAXINE | ACTIVE MOIETY | GRZ5RCB1QG | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | VENLAFAXINE TABLET [AMERICAN HEALTH PACKAGING] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 22980b32-cbae-4f37-9fc0-b47221b2c32e | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | b18d726e-cdb2-4c80-a49d-330cddee17e9 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 6c1d0d4f-c8e2-4035-8f4e-7a46bfe3f059 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | b055df74-51f9-401f-8cca-24269a0163df | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 0c404290-2806-4756-bca3-2d639b400963 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| venlafaxine hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | de6e30f8-c8ef-4016-b228-0f188645347b | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 92b3f73d-d6ca-4d7d-9035-5700f527cb85 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Preferred Pharmaceuticals, Inc. | 653f3f95-98d0-4ce0-bf10-ac7938be690e | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine | VENLAFAXINE | Bryant Ranch Prepack | d4638a83-2720-430c-b529-c852aa2f7366 | 2025-09-26 | Boxed warning, Warnings, Adverse reactions | ANDA077653 313580 7D7RX5A8MO |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b52f29-c1a0-c673-e063-6294a90a9a7a | 2025-09-05 | Warnings | 1K09F3G675 |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 08b8003f-40be-3380-e063-6294a90a4f6b | 2025-09-05 | Warnings | 1K09F3G675 |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 3cbe3e18-9a7e-aaa3-e063-6394a90abf92 | 2025-08-19 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | FSA Store Inc. | 3cd18f96-34f7-3f2c-e063-6294a90a3b7e | 2025-08-19 | Warnings | 1K09F3G675 |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | Marlex Pharmaceuticals, Inc. | 3c2e188f-76aa-a022-e063-6294a90abfc9 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | Trigen Laboratories, LLC | fdaed1c2-dd0a-4bf3-975a-86fe3e7f0c97 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | Alembic Pharmaceuticals Inc. | 5c943206-6df8-4fc5-ab1d-d34b9715182c | 2025-07-24 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Ferrum rosatum Graphites | FERRUM ROSATUM GRAPHITES | Uriel Pharmacy Inc. | 1a4ca338-eada-4c0f-8bce-480244940c89 | 2025-06-27 | Warnings | 1K09F3G675 |
| Venlafaxine Hydrochloride | VENLAFAXINE HYDROCHLORIDE | American Health Packaging | e05bdeb4-07a9-441e-901b-f2aea550db2b | 2025-06-24 | Boxed warning, Warnings, Adverse reactions | 7D7RX5A8MO |
| Venlafaxine | VENLAFAXINE | NuCare Pharmaceuticals,Inc. | fa1db21b-98b8-3bde-e053-6394a90aa638 | 2025-06-09 | Boxed warning, Warnings, Adverse reactions | ANDA077653 313586 7D7RX5A8MO |
| Aquavit | AQUAVIT | Uriel Pharmacy Inc. | c1c0887a-c388-c737-e053-2a95a90a076c | 2025-06-06 | Warnings | 1K09F3G675 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.